These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38700729)
1. Anticholinergic Burden in Patients Treated for Overactive Bladder: Second-Line Therapy with Tibial Nerve Stimulation as a Solution. Satyadev N; Ameen M; Do TH; Wang H Int Urogynecol J; 2024 Jul; 35(7):1375-1379. PubMed ID: 38700729 [TBL] [Abstract][Full Text] [Related]
2. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Rai BP; Cody JD; Alhasso A; Stewart L Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594 [TBL] [Abstract][Full Text] [Related]
3. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis. Alomari MS; Abdulhamid AS; Ghaddaf AA; Alshareef KM; Haneef AK; AlQuhaibi MS; Banjar RA Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082 [TBL] [Abstract][Full Text] [Related]
4. Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review. Sayner AM; Rogers F; Tran J; Jovanovic E; Henningham L; Nahon I Neuromodulation; 2022 Dec; 25(8):1086-1096. PubMed ID: 35688702 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial. Sonmez R; Yildiz N; Alkan H Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090 [TBL] [Abstract][Full Text] [Related]
6. Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices. Lee UJ; MacDiarmid S; Matthews CA; Gillespie E; Peters KM Adv Ther; 2024 Jul; 41(7):2635-2654. PubMed ID: 38748331 [TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial. Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804 [TBL] [Abstract][Full Text] [Related]
8. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder. Zonić-Imamović M; Sinanović O; Imamović M; Muftić M; Janković S; Bazardžanović M Acta Med Acad; 2021 Aug; 50(2):235-243. PubMed ID: 34847676 [TBL] [Abstract][Full Text] [Related]
9. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). Martin-Garcia M; Crampton J Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384 [TBL] [Abstract][Full Text] [Related]
10. Effects of Treating an Overactive Urinary Bladder in Patients with Multiple Sclerosis. Zonić-Imamović M; Imamović S; Čičkušić A; Delalić A; Hodžić R; Imamović M Acta Med Acad; 2019 Dec; 48(3):271-277. PubMed ID: 32124625 [TBL] [Abstract][Full Text] [Related]
12. Transcutaneous tibial nerve stimulation: 2 years follow-up outcomes in the management of anticholinergic refractory overactive bladder. Leroux PA; Brassart E; Lebdai S; Azzouzi AR; Bigot P; Carrouget J World J Urol; 2018 Sep; 36(9):1455-1460. PubMed ID: 29633085 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial. Preyer O; Umek W; Laml T; Bjelic-Radisic V; Gabriel B; Mittlboeck M; Hanzal E Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262 [TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome. Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624 [TBL] [Abstract][Full Text] [Related]
15. Is the addition of vaginal electrical stimulation to transcutaneous tibial nerve electrical stimulation more effective for overactive bladder treatment? A randomized controlled trial. Bacchi Ambrosano Giarreta F; Milhem Haddad J; Souza de Carvalho Fusco HC; Chada Baracat E; Casarotto RA; Alves Gonçalves Ferreira E Actas Urol Esp (Engl Ed); 2021; 45(1):64-72. PubMed ID: 32660872 [TBL] [Abstract][Full Text] [Related]
16. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator. Kapur A; Aalami Harandi A; Hartman-Kenzler J; Kim J Neurourol Urodyn; 2024 Apr; 43(4):959-966. PubMed ID: 38390786 [TBL] [Abstract][Full Text] [Related]
17. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review. Booth J; Connelly L; Dickson S; Duncan F; Lawrence M Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583 [TBL] [Abstract][Full Text] [Related]
18. Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study. Boudaoud N; Binet A; Line A; Chaouadi D; Jolly C; Fiquet CF; Ripert T; Merol ML J Pediatr Urol; 2015 Jun; 11(3):138.e1-10. PubMed ID: 25979217 [TBL] [Abstract][Full Text] [Related]
19. The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin? Tubaro A; Puccini F; De Nunzio C Curr Opin Urol; 2015 Jul; 25(4):305-10. PubMed ID: 26049873 [TBL] [Abstract][Full Text] [Related]